
Inscripta announces strategic acquisition of Solana Biosciences
BOULDER -- Inscripta , a leading gene-editing technology company, today announced the strategic acquisition of Solana Biosciences, a life sciences company founded by Illumina (NASDAQ: ILMN)... Read More
Thursday September 6, 2018